Department of Medical Sciences

Department of Medical ... Research Endocrine tumour biology Publications

Denna sida på svenska

Publications from Endocrine Tumour Biology

These are the 50 most recent publications from the reseasrch group Endocrine Tumour Biology.

Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation.

Kjaer, Josefine; Smith, Sara; Hellman, Per; Stålberg, Peter et al.

Part of World Journal of Surgery, p. 340-347, 2023.

Article in journal

DOI for Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation. Download full text (pdf) of Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation.

Open access
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours

Dromain, Clarisse; Vullierme, Marie-Pierre; Hicks, Rodney J.; Prasad, Vikas et al.

Part of Journal of neuroendocrinology, 2022.

Article in journal

DOI for ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours Download full text (pdf) of ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours

Open access
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Kjaer, Josefin; Clancy, Thomas E.; Thornell, Anders; Andersson, Niklas et al.

Part of Annals of Surgery Open, 2022.

Article in journal

DOI for Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study Download full text (pdf) of Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Open access
Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Mollazadegan, Kazhan; Skogseid, Britt; Botling, Johan; Åkerström, Tobias et al.

Part of Endocrine Connections, 2022.

Article in journal

DOI for Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors Download full text (pdf) of Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Open access
A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires

van Leeuwaarde, Rachel S.; Gonzalez-Clavijo, Angelica M.; Pracht, Marc; Emelianova, Galina et al.

Part of Journal of Clinical Medicine, 2022.

Article in journal

DOI for A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires Download full text (pdf) of A Multinational Pilot Study on Patients' Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires

Open access
Targeted Therapies in Pheochromocytoma and Paraganglioma

Wang, Katharina; Crona, Joakim; Beuschlein, Felix; Grossman, Ashley B. et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 2963-2972, 2022.

Article, review/survey

DOI for Targeted Therapies in Pheochromocytoma and Paraganglioma
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

Ambrosini, Valentina; Kunikowska, Jolanta; Baudin, Eric; Bodei, Lisa et al.

Part of European Journal of Cancer, p. 56-73, 2021.

Article, review/survey

DOI for Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Cardiac Imaging in Carcinoid Heart Disease

Baron, Tomasz; Bergsten, Johannes; Albåge, Anders; Lundin, Lennart et al.

Part of JACC Cardiovascular Imaging, p. 2240-2253, 2021.

Article in journal

DOI for Cardiac Imaging in Carcinoid Heart Disease
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma

Crona, Joakim; Baudin, Eric; Terzolo, Massimo; Chrisoulidou, Alexandra et al.

Part of European Journal of Endocrinology, p. R51-R59, 2021.

Article, review/survey

DOI for ENSAT registry-based randomized clinical trials for adrenocortical carcinoma
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours

Dawod, Mohammed; Alonso Gordoa, Teresa; Cives, Mauro; De Mestier, Louis et al.

Part of Current Treatment Options in Oncology, 2021.

Article, review/survey

DOI for Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours
Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability

Dromain, Clarisse; Sundin, Anders; Najran, Pavan; Vidal Trueba, Hector et al.

Part of Neuroendocrinology, p. 831-839, 2021.

Article in journal

DOI for Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability
177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Part of Neuroendocrinology, p. 330-343, 2021.

Article in journal

DOI for 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants Download full text (pdf) of 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Open access
High-Specific-Activity-¹³¹I-MIBG versus ¹⁷⁷Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma

Jha, Abhishek; Taïeb, David; Carrasquillo, Jorge A.; Pryma, Daniel A. et al.

Part of Clinical Cancer Research, p. 2989-2995, 2021.

Article in journal

DOI for High-Specific-Activity-¹³¹I-MIBG versus ¹⁷⁷Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment

Lamarca, Angela; Cives, Mauro; de Mestier, Louis; Crona, Joakim et al.

Part of World Journal of Gastroenterology, p. 976-989, 2021.

Article in journal

DOI for Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment

Open access
MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines

Li, Su-Chen; Monazzam, Azita; Razmara, Masoud; Chu, Xia et al.

Part of Scientific Reports, 2021.

Article in journal

DOI for MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines Download full text (pdf) of MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines

Open access
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility

Modlin, I. M.; Kidd, M.; Falconi, M.; Filosso, P. L. et al.

Part of Annals of Oncology, p. 1425-1433, 2021.

Article in journal

DOI for A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)

Modlin, Irvin M.; Kidd, Mark; Öberg, Kjell; Falconi, Massimo et al.

Part of Annals of Surgical Oncology, p. 7506-7517, 2021.

Article in journal

DOI for Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)

Open access
Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma

Mollazadegan, Kazhan; Welin, Staffan; Crona, Joakim

Part of Current Treatment Options in Oncology, 2021.

Article, review/survey

DOI for Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma Download full text (pdf) of Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma

Open access
¹⁸F-Radiolabeling and Preliminary Evaluation of a HSP₉₀ ligand

Nordeman, Patrik; Jayendra, Z. P.; Briard, E.; Li, Su-Chen et al.

Part of European Journal of Pharmaceutical Sciences, 2021.

Article in journal

DOI for ¹⁸F-Radiolabeling and Preliminary Evaluation of a HSP₉₀ ligand
Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.

Pettersson, Olof; Fröss-Baron, Katarzyna; Crona, Joakim; Sundin, Anders

Part of Endocrine Connections, p. 422-431, 2021.

Article in journal

DOI for Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE. Download full text (pdf) of Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.

Open access
Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging

Silins, Isabella; Sundin, Anders; Nordeman, Patrik; Jahan, Mahabuba et al.

Part of International Journal of Medical Sciences, p. 2187-2196, 2021.

Article in journal

DOI for Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging Download full text (pdf) of Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging

Open access
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE

Strosberg, Jonathan R.; Srirajaskanthan, Rajaventhan; El-Haddad, Ghassan; Wolin, Edward M. et al.

Part of Journal of Nuclear Medicine, p. 1712-1718, 2021.

Article in journal

DOI for Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE Download full text (pdf) of Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE

Open access
Whole genome sequencing of apparently mutation-negative MEN1 patients

Backman, Samuel; Bajic, Duska; Crona, Joakim; Hellman, Per et al.

Part of European Journal of Endocrinology, p. 35-45, 2020.

Article in journal

DOI for Whole genome sequencing of apparently mutation-negative MEN1 patients
High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Botling, Johan; Lamarca, Angela; Bajic, Duska; Norlén, Olov et al.

Part of Neuroendocrinology, p. 891-898, 2020.

Article in journal

DOI for High-grade progression confers poor survival in pancreatic neuroendocrine tumors
Neuroendocrine Neoplasms of the Small Bowel and Pancreas

Clift, Ashley Kieran; Kidd, Mark; Bodei, Lisa; Toumpanakis, Christos et al.

Part of Neuroendocrinology, p. 444-476, 2020.

Article in journal

DOI for Neuroendocrine Neoplasms of the Small Bowel and Pancreas
Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker

Ghosal, Suman; Das, Shaoli; Pang, Ying; Gonzales, Melissa K. et al.

Part of International Journal of Cancer, p. 2326-2335, 2020.

Article in journal

DOI for Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension

Lenders, Jacques W. M.; Kerstens, Michiel N.; Amar, Laurence; Prejbisz, Aleksander et al.

Part of Journal of Hypertension, p. 1443-1456, 2020.

Article in journal

DOI for Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis

Malczewska, Anna; Kidd, Mark; Matar, Somer; Kos-Kudla, Beata et al.

Part of Neuroendocrinology, p. 198-216, 2020.

Article, review/survey

DOI for An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

Malczewska, Anna; Kos-Kudla, Beata; Kidd, Mark; Drozdov, Ignat et al.

Part of Advances in Medical Sciences, p. 18-29, 2020.

Article, review/survey

DOI for The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors Download full text (pdf) of The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

Open access
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms

Matar, Somer; Malczewska, Anna; Öberg, Kjell; Bodei, Lisa et al.

Part of Neuroendocrinology, p. 185-197, 2020.

Article in journal

DOI for Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms
Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line

Monazzam, Azita; Li, Su-Chen; Wargelius, Hanna-Linn; Razmara, Masoud et al.

Part of Scientific Reports, 2020.

Article in journal

DOI for Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line Download full text (pdf) of Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line

Open access
Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation

Paulsson, Johan O.; Backman, Samuel; Wang, Na; Stenman, Adam et al.

Part of Journal of Pathology, p. 183-194, 2020.

Article in journal

DOI for Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Pavel, M.; Öberg, Kjell; Falconi, M.; Krenning, E. P. et al.

Part of Annals of Oncology, p. 844-860, 2020.

Article in journal

DOI for Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Pettersson, Olof; Fröss-Baron, Katarzyna; Crona, Joakim; Sundin, Anders

Part of Frontiers in Oncology, 2020.

Article in journal

DOI for Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients Download full text (pdf) of Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Open access
Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Sandström, Mattias; Freedman, Nanette; Fröss-Baron, Katarzyna; Khan, Tanweera et al.

Part of EJNMMI Physics, 2020.

Article in journal

DOI for Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points Download full text (pdf) of Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Open access
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study

Strosberg, Jonathan; Kunz, Pamela L.; Hendifar, Andrew; Yao, James et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 2372-2382, 2020.

Article in journal

DOI for Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study Download full text (pdf) of Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-177-Dotatate: an analysis of the NETTER-1 study

Open access
Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.

Tholander, Bengt; Koliadi, Anthoula; Botling, Johan; Dahlstrand, Hanna et al.

Part of Upsala Journal of Medical Sciences, p. 325-329, 2020.

Article in journal

DOI for Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma.
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome

Anthony, Lowell B.; Kulke, Matthew H.; Caplin, Martyn E.; Bergsland, Emily et al.

Part of The Oncologist, p. E662-E670, 2019.

Article in journal

DOI for Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome
Expanding the phenotypic spectrum of osteogenesis imperfecta type V including heterotopic ossification of muscle origins and attachments

Clewemar, Pantelis; Hailer, Nils P.; Hailer, Yasmin; Klar, Joakim et al.

Part of Molecular Genetics & Genomic Medicine, 2019.

Article in journal

DOI for Expanding the phenotypic spectrum of osteogenesis imperfecta type V including heterotopic ossification of muscle origins and attachments Download full text (pdf) of Expanding the phenotypic spectrum of osteogenesis imperfecta type V including heterotopic ossification of muscle origins and attachments

Open access
Adrenocortical carcinoma: towards genomics guided clinical care

Crona, Joakim; Beuschlein, Felix

Part of Nature Reviews Endocrinology, p. 548-560, 2019.

Article, review/survey

DOI for Adrenocortical carcinoma: towards genomics guided clinical care
Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis

Crona, Joakim; Lamarca, Angela; Ghosal, Suman; Welin, Staffan et al.

Part of Endocrine-Related Cancer, p. 539-550, 2019.

Article, review/survey

DOI for Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis
Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms

Daskalakis, Kosmas; Chatzelis, Eleftherios; Tsoli, Marina; Papadopoulou-Marketou, Nektaria et al.

Part of Endocrine (Basingstoke), p. 384-392, 2019.

Article in journal

DOI for Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms Download full text (pdf) of Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms

Open access
Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Georgantzi, Kleopatra; Tsolakis, Apostolos V.; Jakobson, Åke; Christofferson, Rolf et al.

Part of Endocrine pathology, p. 173-179, 2019.

Article in journal

DOI for Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma Download full text (pdf) of Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Open access
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome

Hudgens, Stacie; Ramage, John; Kulke, Matthew; Bergsland, Emily et al.

Part of JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019.

Article in journal

DOI for Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome Download full text (pdf) of Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome

Open access
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET): The GREPONET Study

Lamarca, Angela; Crona, Joakim; Ronot, Maxime; Opalinska, Marta et al.

Part of The Oncologist, p. E1082-E1090, 2019.

Article in journal

DOI for Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET): The GREPONET Study
Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours: the GREPONET-2 study

Lamarca, Angela; Ronot, Maxime; Moalla, Salma; Crona, Joakim et al.

Part of Clinical Cancer Research, p. 6692-6699, 2019.

Article in journal

DOI for Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours: the GREPONET-2 study
NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging

Malczewska, Anna; Witkowska, Magdalena; Makulik, Karolina; Bocian, Agnes et al.

Part of Endocrine Connections, p. 442-453, 2019.

Article in journal

DOI for NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging Download full text (pdf) of NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging

Open access
NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease

Malczewska, Anna; Öberg, Kjell; Bodei, Lisa; Aslanian, Harry et al.

Part of Neuroendocrinology, p. 219-231, 2019.

Article in journal

DOI for NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease
Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma

Muth, A.; Crona, Joakim; Gimm, O.; Elmgren, A. et al.

Part of Journal of Internal Medicine, p. 187-204, 2019.

Article, review/survey

DOI for Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma
Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)

Strom, Torbjorn; Kozlovacki, Gordana; Myrenfors, Peter; Almquist, Martin

Part of Patient Preference and Adherence, p. 1799-1807, 2019.

Article in journal

DOI for Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET) Download full text (pdf) of Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)

Open access

Last modified: 2022-06-09